The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Publication of Admission Document

28 May 2020 07:30

RNS Number : 1963O
Trident Resources Plc
28 May 2020
 

 

 

28 May 2020

 

 

TRIDENT RESOURCES PLC

("Trident" or the "Company")

 

Publication of Admission Document

 

Admission to trading on AIM

 

 

Trident Resources plc (LSE:TRR) (to be renamed Trident Royalties plc) is pleased to announce that it has published its admission document and has applied for the admission to trading of its entire issued and to be issued ordinary share capital to trading on the AIM market of the London Stock Exchange ("Admission"). The admission document is available at the Company's website: www.tridentroyalties.com.

 

Admission and commencement of dealings in the ordinary shares in the Company is expected to take place at 8:00 a.m. on 2 June 2020.

 

Grant Thornton is acting as Nominated Adviser to the Company.

 

 

ENQUIRIES

 

Trident Resources Plc

Adam Davidson

www.tridentroyalties.com

+1 (757) 208-5171

Grant Thornton LLP

Seamus Fricker

www.grantthornton.co.uk

+44 207 865 2050

Tamesis Partners LLP

Richard Greenfield

www.tamesispartners.com

+44 203 882 2868

Yellow Jersey

Charles Goodwin

www.yellowjerseypr.com

+44 203 004 9512

Azure Capital Ltd

John Toll

www.azurecapital.com.au

+61 8 6263 0888

Ashanti Capital Pty Ltd

Rob Hamilton

www.ashanticapital.com.au

+61 8 6169 2668

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUWUNRRVUVURR

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.